openPR Logo
Press release

Oligonucleotide Delivery System Market Key Players Analysis - Biogen, Sarepta Therapeutics, Inc., Jazz Pharmaceuticals plc, Ionis Pharmaceuticals, Inc.

05-05-2025 12:42 PM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

Oligonucleotide Delivery System Market

Oligonucleotide Delivery System Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oligonucleotide Delivery System Market Size, Share & Trends Analysis Report By Delivery System (Conjugation-Based Delivery Systems (GALNAc Conjugation, Ligand Conjugation, Antibody Conjugation, Targeting Moiety Conjugation), Nanoparticle-Based Delivery Systems (Lipid Nanoparticles (LNPs), Peptide Nanoparticles), Viral Vector-Based Delivery Systems (Adeno-associated Virus (AAV) Vectors, AAV9, Lentiviral Vectors, Others), Exosome-Based Delivery Systems, Liposomes, Others), Disease Indication (Genetic Disorders, Infectious Diseases, Oncology, Neurological Disorders, Others (Autoimmune Diseases, Metabolic Disorders, etc.))- Market Outlook And Industry Analysis 2031"

The Global Oligonucleotide Delivery System Market is predicted to grow with a CAGR of 12.4% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2779

The oligonucleotide delivery system market is experiencing rapid growth within the biotechnology and pharmaceutical sectors, as it focuses on the efficient transport of oligonucleotide-based therapeutics to targeted cells. Oligonucleotides, short sequences of nucleic acids, have emerged as powerful tools for gene regulation and therapeutic interventions. These molecules hold significant promise in treating a wide range of diseases, including genetic disorders, cancers, and infectious diseases. However, due to their instability and inability to easily cross biological barriers, effective delivery systems are essential to ensure that these molecules reach their intended site of action without degradation. Such delivery systems play a critical role in enhancing the therapeutic efficacy of oligonucleotides, positioning them as promising candidates for the future of medicine.

Oligonucleotide delivery systems are utilized in the treatment of various conditions, including genetic disorders, cancer, infectious diseases, and neurological disorders. Delivery technologies include conjugation-based approaches, such as chemically linking oligonucleotides to carriers, nanoparticle-based systems for protection and transport, viral vector-based direct delivery, exosome-based natural carriers, and liposome-based vesicles to improve stability. These innovative delivery mechanisms are essential for advancing targeted gene therapies. As research progresses, the approval of additional oligonucleotide-based treatments is expected, providing more therapeutic options for addressing complex diseases.

List of Prominent Players in the Oligonucleotide Delivery System Market:
• Biogen
• Sarepta Therapeutics, Inc.
• Jazz Pharmaceuticals plc
• Ionis Pharmaceuticals, Inc.
• Nippon Shinyaku Co., Ltd.
• AstraZeneca
• Alnylam Pharmaceuticals, Inc.
• Novartis AG
• Dicerna Pharmaceuticals, Inc. (Novo Nordisk)
• IVERIC bio, Inc. (Astellas Pharma Inc.)
• Elsie Biotechnologies (GSK)

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics:
Drivers:
The growth of the oligonucleotide delivery system market is propelled by several key factors, including the rising demand for targeted therapies, advancements in delivery technologies, regulatory approvals, and the increasing prevalence of genetic disorders and cancer. Personalized medicine plays a pivotal role in driving the need for oligonucleotide-based treatments, such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), which require efficient delivery mechanisms. Ongoing innovations in nanoparticle-based systems, viral vectors, and conjugation strategies are enhancing the stability, cellular uptake, and tissue targeting of these therapies. The approval of novel drugs, such as ONPATTRO and GIVLAARI, has bolstered confidence in the technology, resulting in heightened investments. The rising incidence of genetic disorders and cancer, coupled with increased research and development efforts, further fuels market growth.

Challenges:
The development of oligonucleotide delivery systems faces several challenges, particularly concerning efficiency, stability, targeting precision, and safety. Oligonucleotides are prone to degradation and struggle to cross biological barriers, which negatively impacts their therapeutic effectiveness. Achieving accurate tissue targeting remains a challenge, often leading to off-target effects. Additionally, the development of immune responses and the risk of immunogenicity further complicate the safe application of these therapies. Addressing these challenges is crucial for the continued advancement of oligonucleotide-based treatments.

Regional Trends:
North America currently dominates the oligonucleotide delivery system market, followed by Europe and Asia. The region's leadership is attributed to its robust research infrastructure, substantial investments in life sciences, a favorable regulatory environment, and a high incidence of genetic disorders. The presence of innovative biotechnology companies, research institutions, and universities creates a conducive environment for the development of oligonucleotide-based therapies. Furthermore, strong investment in personalized therapeutics, along with support from the U.S. Food and Drug Administration (FDA), has accelerated market growth. The increasing prevalence of genetic disorders and cancers necessitates effective treatment options, and industry leaders, including Biogen, Alnylam Pharmaceuticals, and Ionis Pharmaceuticals, have already established a strong market presence in the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2779

Recent Developments:
• In April 2024, Nippon Shinyaku Co., Ltd has announced a joint research agreement with MiNA Therapeutics to develop nucleic acid medicines targeting intractable and rare diseases in the central nervous system.
• In July 2023, Novartis has announced the acquisition of DTx Pharma, a preclinical-stage biotechnology company based in San Diego, which specializes in using its proprietary FALCON platform to develop siRNA therapies for neuroscience applications.

Segmentation of Oligonucleotide Delivery System Market-
Oligonucleotide Delivery System Market- By Delivery System
• Conjugation-Based Delivery Systems
o GALNAc Conjugation
o Ligand Conjugation
o Antibody Conjugation
o Targeting Moiety Conjugation
• Nanoparticle-Based Delivery Systems
o Lipid Nanoparticles (LNPs)
o Peptide Nanoparticles
• Viral Vector-Based Delivery Systems
o Adeno-associated Virus (AAV) Vectors
o AAV9
o Lentiviral Vectors
o Others
• Exosome-Based Delivery Systems
• Liposomes
• Others
Oligonucleotide Delivery System Market- By Disease Indication
• Genetic Disorders
• Infectious Diseases
• Oncology
• Neurological Disorders
• Others (Autoimmune Diseases, Metabolic Disorders, etc.)
Oligonucleotide Delivery System Market- By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/oligonucleotide-delivery-system-market/2779

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oligonucleotide Delivery System Market Key Players Analysis - Biogen, Sarepta Therapeutics, Inc., Jazz Pharmaceuticals plc, Ionis Pharmaceuticals, Inc. here

News-ID: 3999202 • Views:

More Releases from Insightace Analytic Pvt Ltd.

4PL Logistics Market Revenue Report with Forecast to 2034
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic. Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1609 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global 4PL Logistics Market are: • Rapid growth of automotive the
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to 2034
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034" The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period. Request For Free Sample Pages:
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,

All 5 Releases


More Releases for Delivery

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Last Mile Delivery: Your Fast Track to Delivery Efficiency
The importance of last-mile logistics has increased significantly in recent years due to the rapid growth of e-commerce, evolving consumer demands, and the necessity for efficient and timely deliveries. Covid-19 has also played a part in hastening the rise of last-mile deliveries. In logistics, 'first-mile' and 'last-mile' delivery are terms used to describe the movement of goods within the supply chain. The first leg of the supply chain journey commences
Smart Drug Delivery Systems Market: Revolutionizing Healthcare Delivery
In a rapidly evolving landscape of healthcare, smart drug delivery systems (SDDS) have emerged as a transformative force, catering to the increasing demand for advanced treatment solutions. According to a recent report, the global smart drug delivery systems market was valued at a staggering US$ 8.7 billion in 2022, with projections indicating a remarkable CAGR of 15.2% from 2022 to 2031. By the end of this forecast period, the market
Revolutionizing Last-Mile Delivery: The Growing Delivery Robots Market
"According to the research report, the global delivery robots market was valued at USD 148.07 million in 2022 and is expected to reach USD 2,148.92 million by 2032, to grow at a CAGR of 30.7% during the forecast period." Polaris Market Research has recently published the latest update on Delivery Robots Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis, encompassing its
Nasal Drug Delivery Market - Effortless Delivery, Optimal Results: Nasal Drug De …
Newark, New Castle, USA - new report, titled Nasal Drug Delivery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Nasal Drug Delivery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Nasal Drug Delivery market. The report offers an overview of
Telemedicine Market Report 2022 by Mode of Delivery, End User, Region-Cloud base …
The Telemedicine market will reach US$ 387.7 Mn by 2028 - Persistence Market Research (PMR), a well-known name in market research. The current scenario is such that people and healthcare professionals are increasingly preferring virtual consulting due its low costs and effective treatment. This scenario is, by all means, favoring the Telemedicine market growth. The forecast period (2022-2028) will see North America scale greater heights in the Telemedicine market. This is basically